2010
DOI: 10.4049/jimmunol.0903732
|View full text |Cite
|
Sign up to set email alerts
|

Differential Roles for Endothelial ICAM-1, ICAM-2, and VCAM-1 in Shear-Resistant T Cell Arrest, Polarization, and Directed Crawling on Blood–Brain Barrier Endothelium

Abstract: Endothelial ICAM-1 and ICAM-2 were shown to be essential for T cell diapedesis across the blood–brain barrier (BBB) in vitro under static conditions. Crawling of T cells prior to diapedesis was only recently revealed to occur preferentially against the direction of blood flow on the endothelial surface of inflamed brain microvessels in vivo. Using live cell-imaging techniques, we prove that Th1 memory/effector T cells predominantly crawl against the direction of flow on the surface of BBB endothelium in vitro.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

25
323
2

Year Published

2012
2012
2022
2022

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 233 publications
(364 citation statements)
references
References 37 publications
25
323
2
Order By: Relevance
“…T lymphocytes were allowed to accumulate on the endothelium at low shear stress (0.15 dyn/cm 2 ) and after the accumulation phase flow was increased to physiological shear stress (1.5 dyn/cm 2 ). TEM is initiated by capture of the T lymphocytes to the endothelium during the accumulation phase, followed by the acquisition of a polarized phenotype and an optional crawling step to find permissive sites for diapedesis (24). In contrast to previous studies that addressed effects of Nef on cell adhesion in the absence of physiological shear flow (8,14), WT or F195A Nef did not affect the initial accumulation of T cells on the CCL-21-coated endothelium under our shear-flow conditions (Fig.…”
Section: Hiv-1 Nef Interferes With T-lymphocyte Transmigration Under contrasting
confidence: 51%
See 1 more Smart Citation
“…T lymphocytes were allowed to accumulate on the endothelium at low shear stress (0.15 dyn/cm 2 ) and after the accumulation phase flow was increased to physiological shear stress (1.5 dyn/cm 2 ). TEM is initiated by capture of the T lymphocytes to the endothelium during the accumulation phase, followed by the acquisition of a polarized phenotype and an optional crawling step to find permissive sites for diapedesis (24). In contrast to previous studies that addressed effects of Nef on cell adhesion in the absence of physiological shear flow (8,14), WT or F195A Nef did not affect the initial accumulation of T cells on the CCL-21-coated endothelium under our shear-flow conditions (Fig.…”
Section: Hiv-1 Nef Interferes With T-lymphocyte Transmigration Under contrasting
confidence: 51%
“…Because transmigration across the endothelial cells lining HEVs constitutes a critical step in the homing process, we first addressed whether Nef affects crawling and diapedesis through an endothelial cell monolayer under shear flow (23,24). Transduced and purified T lymphocytes were differentially labeled with CellTracker dyes in vitro, mixed, and perfused over a CCL-21-coated primary brain microvascular endothelial cell monolayer to image the recruitment process by video microscopy over 50 min ( Fig.…”
Section: Hiv-1 Nef Interferes With T-lymphocyte Transmigration Under mentioning
confidence: 99%
“…2B), suggesting that other trafficking cues such as LFA-1/ICAM-1 interaction might maintain this reduced T-cell adhesion to the inflamed spinal cord microvascular wall [31].…”
Section: Lack Of T-cell Rolling Results In Reduced T-cell Adhesion Inmentioning
confidence: 99%
“…Cav-1 levels are known to increase during BBB breakdown following ischemic stroke, when enhanced transcytosis initiates BBB dysfunction (24,25). Finally, healthy BBB vasculature has low levels of leukocyte adhesion molecules, such as vascular cell adhesion molecule (VCAM)-1 and intercellular adhesion molecules (ICAMs)-1 and -2, which are up-regulated on CNS vessels during EAE/MS to promote T-cell trafficking into the parenchyma (26)(27)(28)(29). Blockade of VCAM-1 interactions with its cognate lymphocyte ligand integrin α4 reduces the clinical severity of EAE (30) and is the basis for MS-modifying therapy with natalizumab (31).…”
mentioning
confidence: 99%